Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Human Genetics01:28

Human Genetics

1.7K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

74
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
74
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

63
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
63
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

708
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
708
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

59
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five hundred million years of hunger: how animals evolved to survive essential amino acid scarcity.

Emerging topics in life sciencesĀ·2025
Same author

A mechanism of global gene expression regulation is disrupted by multiple disease states and drug treatments.

PloS oneĀ·2025
Same author

Genomics of Lithium Action and Response.

Focus (American Psychiatric Publishing)Ā·2020
Same author

PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells.

Scientific reportsĀ·2018
Same author

Specialized Information Processing Deficits and Distinct Metabolomic Profiles Following TM-Domain Disruption of Nrg1.

Schizophrenia bulletinĀ·2017
Same author

Copy Number Variations in DISC1 and DISC1-Interacting Partners in Major Mental Illness.

Molecular neuropsychiatryĀ·2016

Related Experiment Video

Updated: Feb 28, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

83.7K

Genomics of Lithium Action and Response.

Benjamin S Pickard1

  • 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK. benjamin.pickard@strath.ac.uk.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|June 23, 2017
PubMed
Summary

Lithium is a key mood stabilizer for bipolar disorder, but its broad actions and varied patient responses are complex. Research is uncovering genetic factors to personalize lithium treatment for better outcomes and fewer side effects.

Keywords:
Bipolar disorderLithiumPharmacogenomicsTherapeutic responseToxicity

More Related Videos

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.5K
Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

10.2K

Related Experiment Videos

Last Updated: Feb 28, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

83.7K
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.5K
Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

10.2K

Area of Science:

  • Psychiatry and Pharmacology
  • Genetics and Genomics
  • Molecular Biology

Background:

  • Lithium is the primary mood stabilizer for bipolar disorder, yet its precise mechanisms remain incompletely understood.
  • Unlike targeted drugs, lithium affects numerous biological pathways, leading to variable treatment responses and side effect profiles.
  • Individual genetic variations significantly influence both lithium efficacy and susceptibility to adverse effects.

Purpose of the Study:

  • To review recent advances in understanding the genetic underpinnings of lithium's therapeutic actions and side effects in bipolar disorder.
  • To explore how transcriptomic, genomic, and cell-model research contributes to defining lithium's biological mechanisms.
  • To discuss the potential for genetically informed, personalized lithium prescription.

Main Methods:

  • Summary and discussion of recent findings from genome-wide association studies (GWAS).
  • Analysis of research utilizing patient-derived cell lines to model lithium's effects.
  • Integration of genetic and transcriptomic data to identify key biological pathways.

Main Results:

  • Progress has been made in identifying genetic factors associated with lithium response and toxicity.
  • Cell-model studies are elucidating specific molecular pathways influenced by lithium.
  • Evidence suggests that genetic variations play a crucial role in mediating lithium's complex effects.

Conclusions:

  • Genuine progress is being made to define clinically useful mechanisms of lithium treatment.
  • Understanding the interplay between genetics and lithium action is vital for contextualizing bipolar disorder pathology.
  • Future research aims to enable targeted lithium prescription for individuals most likely to benefit.